HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
The ISO 13485 standard defines the structure of the quality system applied to medical device manufacturers.
This milestone marks the first certification of our site under this internationally recognized standard, awarded by a highly regarded and demanding notified body.
With this certification, valid for three years, it enables our customers to speed up the submission of their applications to notified organization. This reinforces our customers’ confidence in our quality system.
Thanks to our team and partners for making this achievement possible!
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.